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Abstract
Purpose The incidence of low energy pelvic fractures (FPFs)
in the elderly is increasing. Comorbidities, decreased bone-
quality, problematic fracture fixation and poor compliance
represent some of their specific difficulties. In the absence of
uniform management, a standard operating procedure (SOP)
was introduced to our unit, aiming to improve the quality of
services provided to these patients.
Methods A cohort study was contacted to test the impact of
(1) using a specific clinical algorithm and (2) using different
antiosteoporotic drugs. Multivariate regression analysis was
used to determine prognostic factors. Study endpoints were
the time-to-healing, length-of-stay, return to pre-injury mobil-
ity, union status, mortality and complications.
Results A total of 132 elderly patients (≥65 years) admitted
during the period 2012–2014 with FPFs were enrolled. High-
energy fractures, acetabular fractures, associated trauma af-
fecting mobility, pathological pelvic lesions and operated
FPFs were used as exclusion criteria. Themajority of included
patients were females (108/132; 81.8%), and the mean age
was 85.8 years (range 67–108). Use of antiosteoporotics was
associated with a shorter time of healing (p = 0.036). Patients
treated according to the algorithm showed a significant pro-
tection against malunion (p < 0.001). Also, adherence to the
algorithm allowed more patients to return to their pre-injury
mobility status (p = 0.039).
Conclusions The use of antiosteoporotic medication in elder-
ly patients with fragility pelvic fractures was associated with
faster healing, whilst the adherence to a structured clinical
pathway led to less malunions and non-unions and return to
pre-injury mobility state.
Keywords Elderly . Pelvic fracture . Osteoporosis . Standard
operating procedure . Fragility fractures
Introduction
Pelvic fractures in the elderly are known to have distinct dif-
ferences compared to those in young adults. In the latter, these
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injuries are usually the result of high-energy trauma [1],
whereas in the former group these are mostly low-energy in-
juries, secondary to falls, or repeated stresses to osteopenic/
osteoporotic bone, the so-called Bfragility pelvic fractures^
(FPFs) [2]. Noteworthy, in terms of hospital admissions
FPFs are as common as the high-energy pelvic fractures [3],
and when compared to fragility hip fractures the ratio is equal
to 1:5. The incidence has increased in recent decades, and the
expectations are that this growth will continue mirroring the
ageing of the population, and the increasing awareness of their
significance [4].
Fragility pelvic fractures are thought to be a relatively sim-
ple condition. They have been managed symptomatically for
years, often without complete diagnostic investigations and
limited follow up [5]. However, they can result in significant
morbidity and high costs, including prolonged hospitalization,
decrease in mobility, loss of autonomy, and increase in insti-
tutionalization [6]. The survival of patients with a FPF is sig-
nificantly worse than that of the general population of the
same age, with an even higher mortality than that of patients
with a hip fracture. Interestingly, risk factors and characteris-
tics of FPFs are similar to that of hip fractures: age ≥ 65 years,
female predominance, tendency for falls, and presence of de-
creased bone density [7].
While, significant effort and resources have been invested
globally to optimize the management of fragility hip fractures
(FHFs), FPFs have not received similar attention, and still,
national or international guidelines are not available.
In our institution, it has been our observation that this cohort
of patients has been managed erratically over the years between
different disciplines or even individual clinicians in the absence
of a uniform approach. To address this issue and to implement a
service improvement, we introduced a clinical algorithm (SOP—
standard operating procedure) for elderly patients with FPFs
(Figs. 1 and 2). According to this SOP and since 2011, every
patient admitted with a FPF underwent a CT-scan at the early
stages of admission. Based on an accurate diagnosis of the dis-
ruption of the pelvic ring, each patient, who required non-
operative treatment, was managed according to a structured mo-
bilization plan. Patients who met the indications for operative
treatment followed a similarmobilization pathway postoperative-
ly, aiming to protect the fracture site from secondary displace-
ment and implant failure.
In this study, we tested the hypothesis that elderly patients
with FPFsmanaged non-operatively according to the SOPwould
have improved functional and radiological outcome compared to
patients treated in our unit before the implementation of the SOP.
The patients prior to introduction of the SOPwere managed with
minimal diagnostic imaging, mobilization as pain allowed, and
referral to the orthopaedic trauma department when a complica-
tion occurred. Moreover, we attempted to test the additional hy-
pothesis that the use of antiosteoporotic agents would have a
positive effect on the outcome of these patients.
Methods
In accordance with the NHS act of 2006, section 251, the
study was carried out with the required institutional board
approval under reference number 10444. We performed a co-
hort study over a three-year period: from 1 January 2012 till
31 December 2014. Randomization was not applicable, whilst
blinding was applied during the radiological assessment.
Group A consisted of patients who were managed prior to
the SOP implementation (1 January 2012 to 31 December
2012). Group B (study group) consisted of patients who were
clearly managed with the SOP and their course of treatment
was prospectively documented (1 January 2013 to 31
December 2014).
Inclusion criteria were elderly patients (age ≥ 65 years at
the time of injury) with a low-energy pelvic fracture that were
admitted to our institution. Patients with incomplete imaging,
high-energy trauma, pathological pelvic fractures, pure ace-
tabular fractures, or co-existing other injuries that could inter-
fere with mobilization, as well as operatively-treated FPFs
were excluded.
Data on patient characteristics were collected based on oth-
er publications [2, 8] and clinical endpoints. These included:
patient demographics, injury characteristics, hospitalization
details, comorbidities, imaging results (recent DEXA scans
[± 1 year], X-rays, CT/MRI-scans), adherence or not to the
departmental SOP (Figs. 1 and 2), pre- and post-injury ambu-
lation, residence status, out-patient follow-up at six weeks,
three, six and 12 months, complications and mortality.
Anatomical descriptions were based on multiple classifica-
tion systems, i.e. Tile [9], Burgess et a. [10], Denis et al. [11],
Pohlemann et al. [12] and Starr et al. [13]. The radiological
assessment of the initial fracture type, as well as the progress
of radiological healing was carried out by two independent
raters, blinded to the other study parameters. Diagnosis and
classification of the different pelvic injuries was based on
plain X-ray imaging (AP-pelvis and inlet-outlet images) and/
or subsequent CT/MRI-scans performed at the early stages of
diagnosis (within the first week in group B and within
three weeks in group A).
Sacral lesions were graded according to the Hannover sys-
tem [12] and were divided into two groups: (1) a more stable
group (Hannover type 0-1a-1b), and (2) less stable group
(Hannover 2a-2b-3a-3b-3c-4). Comorbidities were scored
using the Charlson comorbidity index as a quantitative surro-
gate marker of pre-existing medical conditions. Anti-
osteoporotic therapy was defined as the administration of ei-
ther calcium/vitamin D, and/or bisphosphonates, strontium
ranelate, or teriparatide over the period spanning from before
the date of the accident to the first six weeks post-injury.
Taking into account that any anti-osteoporotic therapy needs
a certain period of time since its initiation to have a measur-
able effect on fracture healing [14], we compared patients that
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were under any of these agents or started those within the first
six weeks from their trauma, versus those that did not receive
any therapy for osteoporosis.
Pre- and post-injury mobilization status was categorized
into four categories: 1: unaided community ambulatory, 2:
aided community ambulatory, 3: household ambulatory and
4: non-functional ambulatory.
Radiological healing was assessed via standard
anteroposterior, inlet and outlet X-rays and was defined as
the presence of bridging callus. Malunion was defined as sag-
ittal malrotation or vertical displacement of the hemipelvis of
≥15degrees or ≥10 mm respectively, or a displacement/step
between united fragments of ≥10 mm [15].
Clinical healing was recorded when a physician or attend-
ing physiotherapist recorded pain-free function of the patient
and/or return to pre-injury level of mobility at the outpatient
follow-up appointment or outpatient physiotherapy session.
The pre- and post-injury mobility status was scored in two
ways: by category and by absolute return to pre-injury mobil-
ity (recorded by the attending physiotherapist, or clinician at
follow-up appointments).
The primary endpoint of the study was the time to healing
as recorded either clinically and/or radiologically (whichever
was recorded first). Secondary endpoints were considered the
length of hospital stay (LOS), time to discharge from follow-
up, complications (including non-union and malunion of the
pelvic ring), mortality, return to pre-injury mobility status and
return to pre-injury residence.
Descriptive statistics were used for patient characteristics.
For the statistical analysis, we used R: A language and envi-
ronment for statistical computing. To adjust for confounders,
comparison was done through modelling and consequent ad-
justments. For dichotomous outcomes, multivariable logistic
regression analysis was employed to identify patient charac-
teristics associated with return to pre-injury mobility, compli-
cations, and malunion. A p-value of 10% was used as cut-off
point, as standard errors were expected to be larger in a rela-
tively small data set as the presented one. After the initial
analysis, the multivariable logistic regression analysis was
refitted with only the selected potential risk factors to create
a more parsimonious model so that precision of the estimates
was increased. Odds ratios were reported for comparison.
Fracture healing as an outcome was classified as non-
union, partial union or malunion, or complete union and con-
sequently an ordered logistic regression was employed. For
LOS regression, analysis was undertaken following a loga-
rithm transformation to achieve variance stability. Variables
with a T-value of −1.5 > T < 1.5 were eliminated from the
model. Time-to-healing was modelled with survival models:
initially with Kaplan-Maier survival curves and then with Cox
proportional hazards models. To estimate the value of each
variable the Wald test was used. Interrater reliability for non-
union, union, and malunion was calculated using weighted
kappa-values, and Cohen’s kappa-values were used. P-values
of <0.05 (2-sided) were considered as statistically significant.
Results
During the above pre-specified period, out of 209 consecutive
patients managed in our institution, 132 met the inclusion
criteria (Fig. 3; flowchart of selection criteria). The included
Fig. 1 The algorithm of
non-operative management
(FPF-SOP—standard operating
procedure) of low energy
fractures of the pelvic ring that
was tested in this study. AP
anteroposterior X-ray, CDU
clinical decision unit, CT
computed tomography, D/W
discuss with, FABER test flexion
abduction external rotation test,
FBC full blood count, NSAIDs
non-steroid anti-inflammatory
drugs, RW review, SR senior
registrar, T&O trauma and
orthopaedics
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patients consisted of 108 females (108/132; 81.8%) and 24
males, with a mean age of 85.8 years (SD 7.9; range 67–
108). A total of 130 patients (130/132; 98.5%) underwent
plain X-rays; 113 cases (113/132; 85.6%) had a CT-scan,
and 11 patients (11/132; 8.3%) had a pelvic MRI scan.
Anterior pelvic lesions were documented in 124 patients
(124/132; 93.9%), whereas posterior lesions were noted in
119 cases (119/132; 90.2%).
Of the 121 patients with a superior pubic rami fracture, 102
had also a posterior fracture (102/121; 84.3%). In patients
with a unilateral anterior fracture, the posterior injury was
found on the ipsilateral side in 75.6% of the cases, in 8.9%
on the contralateral side and 15.6% showed a bilateral poste-
rior fracture pattern. Patients with a bilateral anterior fracture
showed an even distribution of right side, left side and bilateral
posterior fractures. LOS was notoriously varied, with a mean
of 22.4 days (SD 19.8) and median 17 days (range 1–106).
Thirty-six patients (27.3%) died within the 12-month follow-
up period, of whom 12 (9%) died without leaving the hospital
following their FPF admission. Analysis for hospital LOSwas
restricted to patients that were discharged alive (120, 91%). Of
132 patients, 43 (43/132;32.6%) had a recorded complication.
Infections were reported in four patients (4/132; 3.0%): one
urinary tract infection and three respiratory tract infections.
Two developed a DVT, and one a pulmonary embolism. A
subsequent fall was reported in 13 patients (13/132; 9.8%) and
six patients had surgery due to new injuries following the
second fall. Eleven (11/132;8.3%) patients died within
six months.
Out of the survivors with complete data on their pre-/post-
injury mobilization data, 60 patients (56.6%) regained their
pre-injury mobility state, 34 (32%) lost a single level, 12
(11.3%) fell back by two levels, whilst 12 had incomplete
observations and 14 died prematurely (Fig. 4). There were
no patients with a better mobility score post-injury than pre-
injury.
Fig. 2 The algorithm of non-operative management (FPF-SOP—
standard operating procedure) of low energy fractures of the pelvic ring
that was tested in this study. AP anteroposterior X-ray, CDU clinical
decision unit, CT computed tomography, D/W discuss with, FABER test
flexion abduction external rotation test, FBC full blood count, NSAIDs
non-steroid anti-inflammatory drugs, RW review, SR senior registrar,
T&O trauma and orthopaedics
1816 International Orthopaedics (SICOT) (2017) 41:1813–1824
The FPF-SOP protocol (group B) was applied in 67 pa-
tients (67/132; 50.8%), with the remaining 65 (65/132;
49.2%) managed without following the protocol, as this was
introduced a year later (group A). More detailed patient char-
acteristics of the groups categorized as to their adherence to
the FPF-SOP are described at Table 1.
During the first six weeks, 87 patients (87/132; 65.9%) were
on anti-osteoporotic medication. The basic characteristics of this
cohort of patients and their outcomes according to the use or not
of antiosteoporotic drugs are presented at Table 2.
Amodel fitting age, gender, following the FPF-SOP protocol,
using anti-osteoporotic medication and sacral fracture severity
was created for regaining absolute pre-injury mobility. It was
found that male gender (OR 5.57), Charlson comorbidity index
(OR 1.24) and following the FPF-SOP protocol (OR 2.54) were
significantly associated with regaining prior mobility (Table 3).
Men, with less unstable pelvic fracture, and unaided commu-
nity pre-injury mobility appeared to be admitted for a period
shorter than the median stay of 17 days, in contrast to female
patients, with more unstable pelvic fractures and problematic
pre-injury mobility. However, the logistic model fitted for age,
gender, following the FPF-SOP protocol, using anti-
osteoporotic medication and sacral fracture severity identified
no significant associations. There was little evidence of associ-
ation for developing a complication or with the LOS with age,
gender, Charlson comorbidity index, using anti-osteoporotic
drug or following the FPF-SOP protocol (Table 3). A more
severe posterior injury (Hannover type ≥2) showed more corre-
lation, however was not statistically significant.
To assess final radiological outcome amultivariatemodel was
fitted including age, male gender, Charlson index, following the
FPF-SOP protocol and use of anti-osteoporotics. Analysing fac-
tors associated with FPF healing, one at a time, we identified that
there was no difference in healing time by age group, Charlson
group or Hannover classification (Table 3). Patients following
the FPF-SOP protocol did not demonstrate a shorter time to
healing, whilst an association was found for male gender with
time of healing, though not significant (p-value 0.063).
The use of anti-osteoporotics (Fig. 5) seemed to have a
significant positive effect also (p-value 0.036), though we
could not distinguish between types of antiosteoporotics.
Fitting a Cox regression model, there was evidence for faster
healing for those prescribed anti-osteoporotic medication (p-
value 0.036).
It was noted that the adherence to the FPF-SOP protocol
led to a better radiological outcome (less malunions; p-value
0.031). Weighted kappa for healing showed agreement of
0.77. A survival approach was used for the analysis of time
to healing, with survival probability translated to healing
probability.
Fig. 4 Patients’mobility score as
recorded reflecting their
pre-injury mobility status and one
recorded at final follow up
Fig. 3 Flowchart of selecting the study cohort of pelvic ring fractures of
patients above 65 years of age that were referred to the department over
the study period 2010–2012
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Table 1 Basic characteristics of
the patients and their outcome
stratified as to the adherence or
not tot the FPF SOP
Group A following
the SOP
Group B Not following
the SOP
General characteristics
Number, % 67, 50.8% 65, 49.2%
Males 13, 19.4% 11, 16.9%
Females 54, 80.6% 54, 83.1%
Age years mean, (SD) 86, (8.1) 84.2, (6.7)
Charlson comorbidity index median, (range) 5.6, (2.4) 5.5, (2.5)
Type of drugs
Vitamin D and calcium 54, 80.6% 30, 46.2%
Bisphosphonates 36, 53.7% 20, 30.8%
Strontium 4, 6% 5, 7.7%
DEXA scan prior to FPF 27, 38.7% 16, 24.6%
Known osteoporosis 20, 29.9% 13, 20%
Diagnosis of the FPFs
With plain x-rays 66, 98.5% 64, 98.5%
With CT scan 57, 85.1% 56, 86.2%
With MRI scan 6, 9% 5, 7.7%
Anterior fractures 60, 91% 61, 93.8%
Nakatani 1 6, 9% 15, 23.1%
Nakatani 2 29, 43.3% 14, 21.5%
Nakatani 3 25, 38.8% 32, 49.2%
Posterior lesions 56, 83.6% 49, 75.4%
Hannover type 1a, 1b 42, 77.6% 29, 44.6%
Hannover type 2a, 2b, 3, 4 12, 17.9% 20, 30.8%
Iliac Blade fracture 2, 3% 6, 9.2%
Pre-injury mobilization status
Unaided community ambulatory 28, 41.8% 26, 40%
Aided community ambulatory 24, 35.8% 27, 41.5%
Household ambulatory 5, 7.5% 4, 6.1%
Non-functional ambulatory 0, 0% 0, 0%
Non-available data 10, 14.9% 8, 12.3%
Post-injury at final follow up mobilization status
Unaided community ambulatory 12, 17.9% 9, 13.8%
Aided community ambulatory 32, 47.8% 19, 29.2%
Household ambulatory 10, 14.9% 15, 23.1%
Non-functional ambulatory 0, 0% 4, 6.2%
Died earlier 8, 11.9% 4, 6.2%
Non-available data 5, 7.7% 14, 21.5%
Outcome
LOS in days mean, (SD) 21.5, (19) 21, (18.5)
Union 43, 64.2% 27, 41.5%
Malunion 4, 6% 17, 26.2%
Nonunion 2, 3% 2, 3.1%
Time to radiological healing mean, (SD) 168 days (229.7) 166.2 days (231.5)
Time to clinical healing mean, (SD) 139.8 days (116.6) 138.1 days (117.4)
Complications 25, 37.3% 26, 40%
Death in-hospital within the same admission 3, 4.5% 9, 13.8%
Death within 12 months from FPF 18, 26.9% 26, 40%
Return to pre-injury residence 35, 52.2% 46, 70.8%
Restoration of the pre-injury mobility status 38, 56.7% 22, 33.8%
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Discussion
The objective of this study was to determine the effect of using
a specific management protocol and the use of anti-
osteoporotic medication on fracture healing in low energy
pelvic fractures in the elderly population.
It is our belief that the main goal of treatment for the FPFs
should be similar to that of hip fractures: focusing on the
optimisation of medical comorbidities, early ambulation, and
early hospital discharge to an appropriate facility. A signifi-
cant difference to the hip fractures is the fact that the FPFs
mainstay of treatment is non-operative. This approach is due
to the following: (a) a significant proportion of these fractures
are thought to be mechanically stable; (b) limitations of cur-
rent pelvic fixation techniques in the presence of severe oste-
oporosis; (c) the high perioperative morbidity of open pelvic
surgery in this frail cohort of patients; and finally, (d) the
relatively scarce availability of trained pelvic trauma surgeons.
Nevertheless, there are specific indications for surgical treat-
ment of FPFs, especially of the posterior elements, usually
with minimal invasive or percutaneous techniques [16–18].
It is of interest that inadequate initial management in combi-
nation with the poor bone quality and the slow progress of frac-
ture healing [19] could lead to further displacement of bony
fragments, development of additional fracture lines, secondary
loss of reduction, implant failure, non-union and poor clinical
outcome [18]. Initial imaging in these patients with a suspected
low energy pelvic ring injury is usually limited to plain X-rays.
However, although plain X-rays are considered an adequate tool
for diagnosis of anterior ring pathologies, their accuracy in the
evaluation of posterior pelvic ring lesions is limited, due to the
low bone density, the interposing viscera [6, 16], and theminimal
initial displacement of FPFs. As a result sacral insufficiency frac-
tures are often overlooked in plain X-rays of patients presenting
with low back and/or pelvic pain [20]. Fractures of the pubis,
which are visible on the X-ray, are nearly always associated with
injuries of the posterior pelvic elements [21]. As most forces are
transmitted through the posterior pelvic ring and the posterior
joints [22], posterior fractures are viewed as more crucial than
anterior fractures, and some clinicians and researchers plead for
standardizing the use of CT scans in the diagnosis of elderly
people presenting with low energy pelvic injury [17]. As shown
also to our cohort, balancing decision making on plain imaging
would mislead the mobilization guidance in 24.4%. Having ob-
jective evidence of the posterior pelvic fractures will certainly
have an important part in the positive effect of the protocol, as
this allows for a more effective management in protecting the
affected posterior side in each case. All the above supports our
decision to include an early acquisition of a pelvic CTscan in the
SOP.
In this study, some shortcomings should be considered. As in
every cohort study not all the data were available for every pa-
tient. Also, randomized matched groups could not be evaluated.
With regard to the time of healing, as in all fracture healing
studies, the follow-up is not continuous. Follow-up imaging
and out-patient visits are grossly dependent on logistics of out-
patient departments. In a structured prospective study with set
times of follow-up one might explore these outcomes better.
In general, it is hard to get absolute agreement regarding
fracture healing assessment among clinicians in most clinical
studies. Besides that, the majority of studies do not specify
their definition of healing, or even indicate who functioned as
the observer [23]. In contrast, we attempted to improve by
assigning two blinded independent observers, and our data
analysis demonstrated good consensus.
The concept of acceleration of fracture healing in this group of
patients has attracted significant scientific attention [19, 24].
Consequently, the strategy of using anti-osteoporotic drugs in
the medical treatment of FPFs represents an exciting prospect
[14, 25]. We were not able to distinguish this effect between
different groups of medications, although the literature suggests
a clear positive effect on fracture healing of anabolic type med-
ication [26]. Only a few patients using anti-osteoporotic medica-
tion (N = 9;10.3%) were using strontium ranelate, and no use of
teriparatide was documented. This was against expectations, as
within the FPF-SOP there was clear advice to the patients’
orthogeriatricians/general practitioners to start anabolic agents.
Presumably this reflects the relative high costs of these drugs,
as well as the adherence of primary care physicians to the
existing therapeutic guidelines [27].
However, this study showed that the use of anti-osteoporotic
medication in general, shortens the time to healing significantly
(p = 0.036), confirming our hypothesis. Most patients in the
study that were receiving anti-osteoporotic therapy used
bisphosphonates (N = 57;65.5%), reflecting the existing main-
stream therapeutic protocols in the United Kingdom [27]. In
Table 1 (continued)
Group A following
the SOP
Group B Not following
the SOP
Loss of one level of the pre-injury mobility status 17, 25.4% 17, 26.2%
Loss of two levels of the pre-injury mobility status 5, 7.5% 7, 10.8%
DEXA dual-energy x-ray absorptiometry, FPF fragility pelvic fracture,mmonths, LOS length of stay, SD standard
deviation, SOP standard operating protocol
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Table 2 Basic characteristics of the patients and their outcome stratified as to the use or not of antiosteoporotic agents
Patients group receiving
antiosteoporotic drugs
Patients group not receiving
antiosteoporotic drugs
Patients group with
no available data
General characteristics
Number, % 87, 65.9% 19, 14.4% 26, 19.7%
Males 13, 14.9% 3, 15.8% 8, 30.7%
Females 74, 85.1% 16, 84.2% 18, 69.2%
AGE years mean, (SD) 85.3, (7.6) 83.5, (6.6) 85.6, (8.0)
Charlson comorbidity index median, (range) 5.6 (2.3) 5.4, (1.3) 5.7, (3.2)
Type of drugs
Vitamin D and calcium 84, 96.6% n/a n/a
Bisphosphonates 56, 65.5% n/a n/a
Strontium 9, 10.3% n/a n/a
DEXA scan prior to FPF 33, 37.9% 7, 36.8% 2, 7.7%
Known osteoporosis 25, 28.7% 6, 31.6% 2, 7.7%
Diagnosis of the FPFs
With plain x-rays 87, 100% 18, 94.7% 25, 96.1%
With CT scan 77, 88.5% 17, 89.5% 19, 73.1%
With MRI scan 4, 4.6% 3, 15.8% 4, 15.4%
Anterior fractures 82, 94.3% 18, 94.7% 23, 88.5%
Posterior lesions 73, 83.9% 18, 94.7% 20, 76.9%
Pre-injury mobilization status
Unaided community ambulatory 37, 42.5% 6, 31.6% 10, 38.5%
Aided community ambulatory 32, 36.8% 9, 47.4% 11, 42.3%
Household ambulatory 7, 8% 5.3% 1, 3.8%
Non-functional ambulatory 0, 0% 0, 0% 0, 0%
Non-available data 11, 12.6% 3, 15.8% 4, 15.4%
Post-injury at final follow up mobilization status
Unaided community ambulatory 15, 17.2% 0, 0% 6, 23.1%
Aided community ambulatory 35, 40.2% 14, 73.7% 2, 7.7%
Household ambulatory 22, 25.3% 1, 5.3% 3, 11.5%
Non-functional ambulatory 0, 0% 1, 5.3% 2, 7.7%
Died earlier 4, 4.6% 1, 5.3% 7, 26.9%
Non-available data 11, 12.6% 2, 10.5% 6, 23.1%
Outcome
LOS mean, (SD) 21.5, (17.4) 24.3, (19.6) 21.5, (22.5)
Union 53, 60.9% 11, 57.9% 6, 23.1%
Malunion 9, 10.3% 7, 36.8% 5, 19.2%
Nonunion 2, 2.3% 2, 10.5% 0, 0%
Time to radiological healing mean, (SD) 169.6, (230.5) 177.8, (240.2) 169.9, (233.2)
Time to clinical healing mean, (SD) 140.9, (116.6) 144.9, 122.9) 136.7, (114.1)
Complications 29, 33.3% 5, 26.3% 17, 65.4%
Death in-hospital within the same admission 0, 0% 0, 0% 12, 46.2%
Death within 12 m from FPF 20, 23% 3, 15.8% 21, 80.8%
Return to pre-injury residence 55, 63.2% 14, 73.7% 12, 46.2%
Restoration of the pre-injury mobility status 45, 51.7% 8, 42.1% 7, 26.9%
Loss of one level of the pre-injury mobility status 24, 27.6% 7, 36.8% 3, 11.5%
Loss of two levels of the pre-injury mobility status 8, 9.2% 2, 10.5% 2, 7.7%
DEXA dual-energy x-ray absorptiometry, FPF fragility pelvic fracture, m months, LOS length of stay, SD standard deviation, SOP standard operating
protocol
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Table 3 Effect to the secondary
outcome measures of associated
risk factors as identified and
weighted following logistic
regression analysis
Risk factors Secondary outcomes
First model Corrected model
P-value Odds ratio 95% Confidence interval (CI) P-value
Length of stay (LOS)a
Age 0.46 n/a n/a n/a
Gender (male) 0.30 n/a n/a n/a
Charlson comorbidity index 0.61 n/a n/a n/a
Following the SOP 0.29 n/a n/a n/a
On anti-osteoporotic drugs 0.60 n/a n/a n/a
Hannover >1 0.54 n/a n/a n/a
Complicationsb
Age 0.69 n/a n/a n/a
Gender (male) 0.22 n/a n/a n/a
Charlson index 0.89 n/a n/a n/a
Following the SOP 0.60 n/a n/a n/a
On anti-osteoporotic drugs 0.46 n/a n/a n/a
Hannover >1 0.17 n/a n/a n/a
Malunionb
Age 0.8785 n/a n/a n/a
Gender (male) 0.6951 n/a n/a n/a
Charlson index 0.4964 n/a n/a n/a
Following the SOP 0.0036 0.13 0.03–0.38 0.0006
On anti-osteoporotic drugs 0.4246 n/a n/a n/a
Hannover >1 0.5259 n/a n/a n/a
Time to healingc
Age 0.786 n/a n/a n/a
Gender (male) 0.093 1.71 0.97–3.02 0.063
Charlson index 0.480 n/a n/a n/a
Following the SOP 0.464 n/a n/a n/a
On anti-osteoporotic drugs 0.023 1.79 1.04–3.07 0.036
Nonuniond
Age −0.224 n/a n/a n/a
Gender (male) 0.554 n/a n/a n/a
Charlson index 0.933 n/a n/a n/a
Following the SOP 1.731 2.19 0.031 n/a
On anti-osteoporotic drugs 1.183 n/a n/a n/a
Return to pre-injury mobility statusb
Age 0.2004 n/a n/a n/a
Gender (male) 0.0057 5.57 1.88–18.39 0.0028
Charlson index 0.0336 1.24 1.02–1.55 0.0383
Following the SOP 0.0378 2.54 1.07–6.35 0.0389
On anti-osteoporotic drugs 0.6740 n/a n/a n/a
Hannover >1 0.4784 n/a n/a n/a
In Bold: statistically significant results
LOS length of stay, n/a not applicable, SOP standard operating procedure
Analysis restricted to those discharged alive
a Regression analysis with log transformationb Logistic regression analysis
c Cox regression modeld Polytomous linear regression analysis
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summary, calcium and vitamin D and generic alendronate
(bisphosphonate) are considered as the first line of treatment. If
alendronate is contraindicated, other bisphosphonates, RANKL
inhibitors, or strontium ranelate are used. Parathyroid hormone
peptides (PTH-teriparatide) are only used in patients at very high
risk due to their high cost [28].
The use of bisphosphonates in the presence of a fracture is
associated with concerns of their interaction with bone remodel-
ling and impaired fracture healing. However, studies have shown
larger/stronger callus and delayed remodelling but no evidence of
delayed healing [14]. Studies on RANKL inhibitors showed
greater callus volume and mineral density, and no delay on frac-
ture healing [29]. Experimental data for strontium ranelate range
from no effect to significant increase in both callus volume and
strength [14]. PTH has demonstrated accelerated healing in var-
ious experimental trials in humans [26, 30]. Peichl et al. [26]
showed a significant difference between time to healing in pa-
tients with fragility fractures of the pelvis in patients receiving
PTH 1–84 compared to the control group. The potential effect on
fracture healing of sclerostin blockers is yet to be studied [14].
Our findings underline the theory that the use of
bisphosphonates does not impair fracture healing, and, on the
contrary, seems to enhance it. However, such findings could be
associated with other confounding factors. We suspect that pa-
tients on anti-osteoporotics receive better care in general, and are
better guided by their environment. Also, bisphosphonates are
known to be notoriously difficult to use and are poorly absorbed
from the gastrointestinal tract [31], which makes it more likely
that the outcome is also affected by other variables.
Following the FPF-SOP protocol appeared to protect against
the development ofmalunion (p< 0.001), an associationwhich is
consistent when looking at overall final healing outcome
(p = 0.031). This could be explained as the affected side is more
effectively protected due to the early and accurate diagnosis.
These patients are supported by physiotherapists all the way, as
opposed to having patients mobilized as-pain-allows. Patients
following the protocol were also more than twice as likely to
regain pre-injury mobility (OR = 2.54, p = 0.039). This might
be because they have had better guidance throughout the process.
The use of the SOP was not associated with a reduction of
the LOS. This can possibly be explained due to the fact that
LOS of the elderly in an acute hospital is governed bymultiple
other factors [4]; in most, by the availability of a bed in nurs-
ing homes or short-stay facilities. There might be room for
improvement in the cooperation between hospital and nursing
homes and perhaps a universal protocol can help with that.
The clinical significance of these results is yet to be assessed.
An unexpected result was the significant association
be tween ma l e gende r and r ega in i ng mob i l i t y
(p = 0.003). Males also seem to heal faster, although this
finding did not reach statistical significance (p = 0.063).
This association stands after correction for confounders
such as age and comorbidities. To our knowledge there
are no previous studies that show an association between
male gender and a better outcome after a FPF. The effect
of hormonal metabolism, bone density, and the range of
disabilities may differ between the two genders of the
same age [32] should be further explored as contributors
to the recovery of FPFs.
Conclusions
In conclusion, we observed that the use of anti-osteoporotic
medication and the introduction of a more structured manage-
ment in the form of a protocol have a positive effect on patient
outcome in elderly patients with a fragility fracture of the
pelvis. Using anti-osteoporotic drugs reduces the time of
healing and following the protocol protects against malunion
and gives a better chance of regaining pre-injury mobility.
Fig. 5 Graphic representation of
the positive effect of the use of
antiosteoporotic agents to the
recorded time to clinical/
radiological healing; Kaplan
Meier curve
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